PT-141 (10mg)

What is Dragon Pharma PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide developed for enhancing sexual function and libido. It is derived from the melanocortin receptor system and acts centrally on the brain to stimulate sexual arousal, rather than working on peripheral vasculature. PT-141 has gained attention in research for its potential in male and female sexual dysfunction, low libido, and reproductive health studies. Experimental studies highlight its capacity to improve sexual desire, mood, and overall sexual response, making it a valuable tool in clinical and preclinical research on sexual wellness.

Mechanism of Action:
PT-141 works by activating melanocortin receptors (MC3R and MC4R) in the central nervous system, particularly in the hypothalamus, which regulates sexual arousal and desire. Unlike traditional erectile dysfunction treatments, PT-141 does not act on nitric oxide pathways or vascular mechanisms. Instead, it modulates neurotransmitter release, including dopamine, to enhance sexual motivation and performance. Preclinical studies show that PT-141 influences both male and female sexual behaviors, providing a neuroendocrine approach to treating sexual dysfunction.

Benefits:

• Enhances sexual desire and libido in men and women
• Supports sexual arousal and performance
• May improve mood and motivation related to sexual activity
• Useful for research on sexual dysfunction and reproductive health

Research Applications:

• Investigating male and female sexual dysfunction treatments
• Exploring effects on central nervous system sexual pathways
• Studying neurotransmitter regulation in sexual behavior
• Research on hormonal and behavioral aspects of sexual health

Dosing Instructions:

• Dosing: Reconstitute PT-141 with sterile bacteriostatic water according to manufacturer instructions
• Daily Dose: Typically 1–2 mg per administration, adjusted for study protocols
• Route: Subcutaneous injection, rotating injection sites
• Duration: Research cycles usually 2–4 weeks, depending on study goals
• Frequency: 1–2 times per week in experimental studies
• Recommended Cycles: Structured research cycles with appropriate monitoring
• PCT: Not required as PT-141 does not affect hormonal axis directly

Stacking With Other Products:

• BPC 157 for combined tissue repair and sexual wellness research
• GHK-Cu for synergistic effects on overall vitality and well-being
• CJC-1295 to explore neuroendocrine interactions with growth hormone pathways
• MOTS-c in studies linking metabolism, energy, and sexual performance

Side Effects:

• Mild flushing or warmth after injection
• Temporary nausea or headache
• Occasional increased blood pressure
• Rare dizziness or fatigue

Contraindications:

• Hypersensitivity to PT-141 or peptide excipients
• Pregnancy or breastfeeding due to lack of safety data
• Severe cardiovascular conditions
• Individuals with uncontrolled hypertension or hypotension

Conclusion
PT-141 is a potent melanocortin peptide that enhances sexual desire, arousal, and performance by acting centrally on the brain rather than peripheral vasculature. Its neuroendocrine mechanism provides unique advantages for research in sexual dysfunction, libido disorders, and reproductive health. When properly reconstituted and administered, PT-141 is a valuable experimental tool for understanding sexual physiology and central nervous system modulation, with promising implications for therapeutic development.

References:

• Kingsberg SA, et al. "Bremelanotide (PT-141) for Female Sexual Dysfunction." Journal of Sexual Medicine.
• ClinicalTrials.gov Identifier: NCT02397865 – PT-141 in Hypoactive Sexual Desire Disorder Research.
• O'Neill MF, et al. "Central Melanocortin Pathways in Sexual Arousal." Neuroscience Research.
• Wessells H, et al. "PT-141: Mechanism and Clinical Applications." Current Sexual Health Reports.

PT‑141 FAQ

✔️ What is PT‑141?
PT‑141, also known as Bremelanotide, is a synthetic peptide that has been studied for its ability to interact with melanocortin receptors in the body. It is widely researched for its potential influence on neurological pathways associated with arousal and physiological responses.

✔️ How does PT‑141 differ from traditional compounds used for similar research?
Unlike many compounds that act primarily on the vascular system, PT‑141 works through the central nervous system, targeting melanocortin receptors that may play a role in behavioral and physiological responses.

✔️ What type of research is PT‑141 commonly associated with?
Scientists often investigate PT‑141 in studies related to neuroendocrine signaling, receptor activity, and behavioral response pathways linked to melanocortin receptor activation.

✔️ Why is PT‑141 supplied as a lyophilized peptide vial?
PT‑141 is typically provided as a freeze‑dried (lyophilized) powder to help maintain peptide stability, extend shelf life, and allow proper storage before laboratory preparation.

✔️ How should PT‑141 peptide vials be stored?
To maintain optimal stability, PT‑141 should be kept in a cool, dry environment, ideally refrigerated and protected from direct light and excessive heat.

✔️ What is the significance of melanocortin receptors in PT‑141 research?
Melanocortin receptors are involved in neurological signaling, pigmentation processes, and hormonal pathways, making them a key focus in peptide research involving PT‑141.

✔️ Is PT‑141 related to melanocyte‑stimulating hormones (MSH)?
Yes. PT‑141 is derived from alpha‑melanocyte‑stimulating hormone (α‑MSH) analogs, which are naturally occurring peptides involved in various physiological processes.

✔️ Can improper storage affect PT‑141 peptide quality?
Yes. Exposure to high temperatures, moisture, or direct sunlight may reduce peptide stability and compromise the integrity of the compound.

✔️ What precautions should be taken when handling PT‑141 vials?
PT‑141 should be handled using clean laboratory techniques and sterile equipment to prevent contamination and maintain research reliability.

✔️ Is PT‑141 intended for personal or recreational use?
Peptide vials such as PT‑141 are generally distributed for laboratory research purposes only and should be used by trained professionals within controlled research environments.

Dragon Pharma PT 141 – Storage and Safety

Proper Storage for PT-141
To ensure maximum stability and integrity, PT-141 vials should be stored in a refrigerated environment (2–8°C). Avoid exposure to direct sunlight, heat, or moisture, as these conditions can degrade peptide quality. For long-term storage, it is recommended to freeze the peptide at –20°C, following manufacturer guidelines. Always use sterile containers and minimize repeated freeze-thaw cycles to preserve potency and efficacy.

Handling Safety
PT-141 is intended exclusively for research and laboratory use. Handle the peptide with gloves and protective equipment to prevent contamination. Avoid direct skin contact or ingestion. Researchers should follow standard laboratory safety protocols, including working in a clean, controlled environment.

Reconstitution Guidelines
Before use, PT-141 should be reconstituted with sterile bacteriostatic water or appropriate buffer according to research protocol instructions. Ensure the solution is fully dissolved and gently mixed. Avoid vigorous shaking to prevent peptide denaturation.

General Precautions
Always label vials clearly with product name, lot number, and date of reconstitution. Dispose of any unused material according to institutional biohazard regulations. Store vials in a secure, restricted area away from unauthorized personnel.

Key Takeaways

• Store PT-141 vials in 2–8°C refrigeration; freeze for long-term preservation
• Protect from heat, light, and moisture
• Use sterile equipment and follow laboratory safety standards
• Minimize freeze-thaw cycles to maintain peptide integrity
• Handle exclusively for research purposes

PT-141 from Dragon Pharma Peptides provides high-quality, laboratory-grade peptides with verified authenticity and secure handling instructions for safe and effective research use.